AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2014
Aug 5, 2014
29828_dirs_2014-08-05_b9e21e03-bafa-4d4e-9325-e4a3f5ecd41b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-08-01
Reporting Person: Washington Robin L (EVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-01 | Common Stock | M | 11550 | $19.085 | Acquired | 61382 | Direct |
| 2014-08-01 | Common Stock | M | 4800 | $23.755 | Acquired | 66182 | Direct |
| 2014-08-01 | Common Stock | M | 11250 | $24.295 | Acquired | 77432 | Direct |
| 2014-08-01 | Common Stock | M | 3000 | $24.905 | Acquired | 80432 | Direct |
| 2014-08-01 | Common Stock | S | 22500 | $91.2638 | Disposed | 57932 | Direct |
| 2014-08-01 | Common Stock | S | 8100 | $92.088 | Disposed | 49832 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-08-01 | Non-Qualified Stock Option (right to buy) | $19.085 | M | 11550 | Disposed | 2021-01-20 | Common Stock (11550) | Direct |
| 2014-08-01 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 4800 | Disposed | 2020-01-28 | Common Stock (4800) | Direct |
| 2014-08-01 | Non-Qualified Stock Option (right to buy) | $24.295 | M | 11250 | Disposed | 2022-01-26 | Common Stock (11250) | Direct |
| 2014-08-01 | Non-Qualified Stock Option (right to buy) | $24.905 | M | 3000 | Disposed | 2019-07-29 | Common Stock (3000) | Direct |
Footnotes
F1: The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4: Sale prices reported for the transactions reported here range from $90.70 to $91.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $91.72 to $92.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.